Back to library
GLP-1 / Metabolic
Tirzepatide
Also known as: Mounjaro / Zepbound (research analog)
Dual GIP/GLP-1 receptor agonist studied for glucose control and significant weight reduction.
- Route
- Subcutaneous
- Frequency
- Once weekly, titrated every 4 weeks
- Typical Dose
- 2500–15000 mcg
- 2.5–15 mg
- Average Dose
- 8,750 mcg
- 8.75 mg
- Vial Size
- 10 mg
Supplies for this peptide
Research peptides
Your recommended peptide source. Add their referral URL here.
Affiliate slot — not yet linked
Bacteriostatic water
30 mL sterile multi-use vial for reconstitution.
Affiliate slot — not yet linked
U-100 insulin syringes
0.3 mL or 0.5 mL barrel · 29–31 gauge · box of 100.
Affiliate slot — not yet linked
Outbound links are affiliate placeholders — we may earn a commission on purchases.
Dose Table — Tirzepatide
| Tier | Micrograms (mcg) | Milligrams (mg) | Frequency |
|---|---|---|---|
| Low / Starting | 2,500 mcg | 2.5 mg | Once weekly, titrated every 4 weeks |
| Average | 8,750 mcg | 8.75 mg | Once weekly, titrated every 4 weeks |
| High / Upper | 15,000 mcg | 15 mg | Once weekly, titrated every 4 weeks |
1 mg = 1,000 mcg. Research-reference ranges — not medical advice.
Reconstitution Calculator
Checking access…